Epinastine Hydrochloride Solution/ Drops
Loading...Epinastine Hydrochloride Solution/ Drops Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Epinastine HCl ophthalmic solution, 0.05% is for topical ophthalmic use only and not for injection or oral use.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Epinastine HCl ophthalmic solution, 0.05% is indicated for the prevention of itching associated with allergic conjunctivitis.
History
There is currently no drug history available for this drug.
Other Information
Epinastine HCl ophthalmic solution, 0.05% is a clear, colorless, sterile isotonic solution containing epinastine HCl, an antihistamine and an inhibitor of histamine release from the mast cell for topical administration to the eyes.
Epinastine HCl is represented by the following structural formula:
C16H15N3 ∙ HCl Mol. Wt. 285.78
3-Amino-9, 13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine hydrochloride
Active: Epinastine HCl 0.05% (0.5 mg/mL) equivalent to epinastine 0.044% (0.44 mg/mL); Preservative: Benzalkonium chloride 0.01%; Inactives: Edetate disodium, dihydrate; purified water; sodium chloride; sodium phosphate monobasic, anhydrous; and sodium hydroxide and/or hydrochloric acid (to adjust the pH). Epinastine HCl ophthalmic solution, 0.05% has a pH of approximately 7 and an osmolality range of 250 to 310 mOsm/kg.
Sources
Epinastine Hydrochloride Solution/ Drops Manufacturers
-
Breckenridge Pharmaceutical, Inc.
![Epinastine Hydrochloride Solution/ Drops [Breckenridge Pharmaceutical, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Epinastine Hydrochloride Solution/ Drops | Breckenridge Pharmaceutical, Inc.
The recommended dosage is one drop in each eye twice a day.
Treatment should be continued throughout the period of exposure (i.e., until the pollen season is over or until exposure to the offending allergen is terminated), even when symptoms are absent.
-
Perrigo Company
Epinastine Hydrochloride Solution/ Drops | Perrigo Company
The recommended dosage is one drop in each eye twice a day.
Treatment should be continued throughout the period of exposure (i.e., until the pollen season is over or until exposure to the offending allergen is terminated), even when symptoms are absent.
![Epinastine Hydrochloride Solution/ Drops [Perrigo Company]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=10d2f2e1-6225-4b12-9715-ac893bf58ceb&name=epinastine-hcl-ophthalmic-solution-3.jpg)
Login To Your Free Account